Kyung Hee Lee

Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial

Luis Paz‐Ares, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet · 2019 · 2.2K citations

Medicine, Oncology, Pharmacology +14

Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial

Yung‐Jue Bang, Young‐Woo Kim, Han‐Kwang Yang et al. · The Lancet · 2012 · 1.7K citations

Medicine, Oncology, Surgery +16

Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial

Jonathan W. Goldman, Mikhail Dvorkin, Yuanbin Chen et al. · The Lancet Oncology · 2020 · 687 citations · Full text

Medicine, Oncology, Pharmacology +14

Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer

Yoon Young Choi, Hyunki Kim, Su‐Jin Shin et al. · Annals of Surgery · 2018 · 244 citations · Full text

Medicine, Cancer Biology, Oncology +17

Degradation of atrazine and related s‐triazines

Larry E. Erickson, Kyung Hee Lee, D. D. Sumner · Critical Reviews in Environmental Control · 1989 · 231 citations

Agriculture, Soil Sciences, Weed Science +16